AGM WEBCAST
AGM POWERPOINT
Spotlight
MBP8298 Clinical Trials
BioMS Medical is currently conducting three late-stage clinical trials and one open-label, follow-on trial of MBP8298, for the treatment of multiple sclerosis.
Phase III Canadian & European trial for secondary progressive MS
Phase III U.S. trial for secondary progressive MS
Phase II relapsing-remitting MS trial
BioMS Medical Corp.
TSX: MS
Recent News
May 13, 2008
BioMS Medical to Present at TIDESĀ® Conference
May 13, 2008
BioMS Medical to Present at RODMAN AND RENSHAW Global Healthcare Conference
May 9, 2008
BioMS Medical Provides Update on Pipeline Products
Copyright BioMS Medical 2008
Terms of Use